In A549 lung cancer cells, another study showed that EGFR knockdown reduced the cells’ sensitivity to EGCG, indicating that EGFR signaling pathway suppression may play a major role in EGCG’s anticancer action (Laudadio, Mangano & Minnelli, 2024; Ma et al., 2014). This evidence concerns the gene EGFR and lung cancer.